CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 194 filers reported holding CLOVIS ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $35,893,000 | +165.3% | 3,443,000 | 0.0% | 0.01% | +166.7% |
| Q3 2019 | $13,531,000 | -48.3% | 3,443,000 | +95.6% | 0.00% | -50.0% |
| Q2 2019 | $26,172,000 | +97.8% | 1,760,037 | +230.2% | 0.01% | +100.0% |
| Q1 2019 | $13,229,000 | +38.2% | 533,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $9,573,000 | -38.8% | 533,000 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $15,654,000 | -47.2% | 533,000 | -18.3% | 0.00% | -33.3% |
| Q2 2018 | $29,646,000 | -13.9% | 652,000 | 0.0% | 0.01% | -25.0% |
| Q1 2018 | $34,426,000 | – | 652,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 250,000 | $1,200,000 | 4.04% |
| Palo Alto Investors LP | 4,469,411 | $21,453,000 | 1.12% |
| ARMISTICE CAPITAL, LLC | 2,256,000 | $10,829,000 | 0.37% |
| Vigilare Wealth Management | 32,200 | $155,000 | 0.15% |
| Ikarian Capital, LLC | 650,000 | $3,121,000 | 0.14% |
| Ikarian Capital, LLC | 642,108 | $3,082,000 | 0.14% |
| WELD CAPITAL MANAGEMENT LLC | 40,156 | $193,000 | 0.08% |
| PINNACLE ASSOCIATES LTD | 703,970 | $3,379,000 | 0.07% |
| Versant Venture Management, LLC | 101,855 | $489,000 | 0.05% |
| Kalos Management, Inc. | 23,750 | $114,000 | 0.05% |